Literature DB >> 15450681

Tumor suppressor gene TP53 is genetically associated with schizophrenia in the Chinese population.

Yifeng Yang1, Zeping Xiao, Weixiong Chen, Hong Sang, Yousheng Guan, Yanwei Peng, Diran Zhang, Zhongzhong Gu, Mincai Qian, Guang He, Wei Qin, Dawei Li, Niufan Gu, Lin He.   

Abstract

Schizophrenia is a debilitating mental disorder. The TP53 tumor suppressor gene, encoding a phosphoprotein, is a key element in maintaining genomic stability and cell apoptosis. Recently, reduced risk of cancer in patients of schizophrenia has been reported. Some evidence also suggests the possible implication of TP53 in neurodevelopment. In order to examine the role of the TP53 gene in the pathogenesis of schizophrenic disorders, we investigated the genetic association between a functional polymorphism rs1042522 and schizophrenia by sequencing the fragment covering 72Pro> Arg in 701 cases and 695 controls in this work. In addition, we studied two other SNPs rs2078486 and rs8064946 by allele-specific PCR in the same samples. Though rs1042522 and rs8064946 did not show positive association with schizophrenia, we did observe statistically significant differences on SNP rs2078486 (P-value = 0.029; OR = 1.21; 95% CI 1.02-1.42) and on haplotype CAC (P-value = 0.0068; OR = 1.36; 95% CI 1.09-1.70). These results demonstrated that TP53 might play a role in susceptibility to schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15450681     DOI: 10.1016/j.neulet.2004.07.068

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  Schizophrenia as segmental progeria.

Authors:  Evangelos Papanastasiou; Fiona Gaughran; Shubulade Smith
Journal:  J R Soc Med       Date:  2011-11       Impact factor: 5.344

2.  Investigation of genetic variants in ubiquitin enzyme genes involved in the modulation of neurodevelopmental processes: a role in schizophrenia susceptibility?

Authors:  Jessica L Andrews; Francesca Fernandez-Enright
Journal:  Genet Res (Camb)       Date:  2014-11-24       Impact factor: 1.588

3.  TP53 Polymorphism Contributes to the Susceptibility to Bipolar Disorder but Not to Schizophrenia in the Chinese Han Population.

Authors:  Jialei Yang; Xulong Wu; Jiao Huang; Zhaoxia Chen; Guifeng Huang; Xiaojing Guo; Lulu Zhu; Li Su
Journal:  J Mol Neurosci       Date:  2019-05-05       Impact factor: 3.444

4.  Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability.

Authors:  Katherine E Burdick; Pamela DeRosse; John M Kane; Todd Lencz; Anil K Malhotra
Journal:  Am J Psychiatry       Date:  2010-01-15       Impact factor: 18.112

5.  Association of DRD4 uVNTR and TP53 codon 72 polymorphisms with schizophrenia: a case-control study.

Authors:  For-Wey Lung; Bih-Ching Shu; Wei-Tsung Kao; C Nathan Chen; Yu-Chi Ku; Dong-Sheng Tzeng
Journal:  BMC Med Genet       Date:  2009-12-29       Impact factor: 2.103

6.  The Interaction of TXNIP and AFq1 Genes Increases the Susceptibility of Schizophrenia.

Authors:  Yousong Su; Wenhua Ding; Mengjuan Xing; Dake Qi; Zezhi Li; Donghong Cui
Journal:  Mol Neurobiol       Date:  2016-08-10       Impact factor: 5.590

7.  Phenothiazine Inhibitors of TLKs Affect Double-Strand Break Repair and DNA Damage Response Recovery and Potentiate Tumor Killing with Radiomimetic Therapy.

Authors:  Sharon Ronald; Sanket Awate; Abhijit Rath; Jennifer Carroll; Floyd Galiano; Donard Dwyer; Heather Kleiner-Hancock; J Michael Mathis; Simone Vigod; Arrigo De Benedetti
Journal:  Genes Cancer       Date:  2013-01

Review 8.  Cancer and schizophrenia: is there a paradox?

Authors:  Richard Hodgson; Hiram J Wildgust; Chris J Bushe
Journal:  J Psychopharmacol       Date:  2010-11       Impact factor: 4.153

9.  Analysis of schizophrenia and hepatocellular carcinoma genetic network with corresponding modularity and pathways: novel insights to the immune system.

Authors:  Kuo-Chuan Huang; Ko-Chun Yang; Han Lin; Theresa Tsao Tsun-Hui; Wen-Kuei Lee; Sheng-An Lee; Cheng-Yan Kao
Journal:  BMC Genomics       Date:  2013-10-16       Impact factor: 3.969

10.  TP53 genetic polymorphisms, interactions with lifestyle factors and lung cancer risk: a case control study in a Chinese population.

Authors:  Yanli Li; Shen-Chih Chang; Rungui Niu; Li Liu; Christina R Crabtree-Ide; Baoxing Zhao; Jianping Shi; Xiaoyou Han; Jiawei Li; Jia Su; Lin Cai; Shunzhang Yu; Zuo-Feng Zhang; Lina Mu
Journal:  BMC Cancer       Date:  2013-12-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.